Artificial skin in perspective: Concepts and applications

Pigment Cell and Melanoma Research

Volumn 24, Issue 1, 2011, Pages 35-50

  Brohem, Carla A ^a   Da Silva Cardeal, Laura B ^a   Tiago, Manoela ^a   Soengas, María S ^b   De Moraes Barros, Silvia B ^a   Maria Engler, Silvya S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

3D models; Artificial skin; Organotypical cultures; Rafts; Skin equivalents; Skin reconstructs

Indexed keywords

ARTIFICIAL SKIN; BASEMENT MEMBRANE; CELL INTERACTION; CELL LINE; DERMIS; EPIDERMIS; EXTRACELLULAR MATRIX; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; NONHUMAN; PHOTOAGING; REVIEW; SKIN CANCER; SKIN CELL; SKIN DISEASE; SKIN FIBROBLAST; SKIN FUNCTION; SKIN PIGMENTATION; ULTRAVIOLET RADIATION; WOUND HEALING;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; SKIN; SKIN, ARTIFICIAL; TISSUE ENGINEERING;

ANIMALIA;

EID: 78651414332     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00786.x     Document Type: Review

References (112)

1. Ajani, G., Sato, N., Mack, J.A., and Maytin, E.V. (2007). Cellular responses to disruption of the permeability barrier in a three-dimensional organotypic epidermal model. Exp. Cell Res. 313, 3005-3015.
2. Alt-Holland, A., Shamis, Y., Riley, K.N., DesRochers, T.M., Fusenig, N.E., Herman, I.M., and Garlick, J.A. (2008). E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents. J. Invest. Dermatol. 128, 2498-2507.
3. Asselineau, D., Bernard, B.A., Bailly, C., and Darmon, M. (1985). Epidermal morphogenesis and induction of 67kD keratin polypeptide by culture at the liquid-air interface. Exp. Cell Res. 159, 536-539.
4. Auxenfans, C., Fradette, J., Lequeux, C., Germain, L., Kinikoglu, B., Bechetoille, N., Braye, F., Auger, F.A., and Damour, O. (2008). Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering. Eur. J. Dermatol. 19, 107-113.
5. Balasubramani, M., Kumar, T.R., and Babu, M. (2001). Skin substitutes: a review. Burns 27, 534-544.
6. Barker, C.L., McHale, M.T., Gillies, A.K., Waller, J., Pearce, D.M., Osborne, J., Hutchinson, P.E., Smith, G.M., and Pringle, J.H. (2004). The development and characterization of an in vitro model of psoriasis. J. Invest. Dermatol. 123, 892-901.
7. Bell, E., Ivarsson, B., and Merrill, C. (1979). Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl Acad. Sci. U S A 76, 1274-1278.
8. Bergoglio, V., Warrick, E., Chevallier-Lagente, O., and Magnaldo, T. (2008). Cutaneous gene therapy: the graft takes. Med. Sci. (Paris) 24, 607-614.
9. Berking, C., and Herlyn, M. (2001). Human skin reconstruct models: a new application for studies of melanocyte and melanoma biology. Histol. Histopathol. 16, 669-674.
10. Bernerd, F., and Asselineau, D. (1997). Successive alteration and recovery of epidermal differentiation and morphogenesis after specific UVB-damages in skin reconstructed in vitro. Dev. Biol. 183, 123-138.
11. Bernerd, F., and Asselineau, D. (1998). UVA exposure of human skin reconstructed in vitro induces apoptosis of dermal fibroblasts: subsequent connective tissue repair and implications in photoaging. Cell Death Differ. 5, 792-802.
12. Bernerd, F., and Asselineau, D. (2008). An organotypic model of skin to study photodamage and photoprotection in vitro. J. Am. Acad. Dermatol. 58, S155-S159.
13. Bernerd, F., Vioux, C., and Asselineau, D. (2000). Evaluation of the protective effect of sunscreens on in vitro reconstructed human skin exposed to UVB or UVA irradiation. Photochem. Photobiol. 71, 314-320.
14. Bernerd, F., Asselineau, D., Vioux, C., Chevallier-Lagente, O., Bouadjar, B., Sarasin, A., and Magnaldo, T. (2001). Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro. Proc. Natl Acad. Sci. U S A 98, 7817-7822.
15. Bessou, S., Gauthier, Y., Surlève-Bazeille, J.E., Pain, C., and Taïeb, A. (1997). Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease. Br. J. Dermatol. 137, 890-897.
16. Bissell, M.J., Hall, H.G., and Parry, G. (1982). How does the extracellular matrix direct gene expression? J. Theor. Biol. 99, 31-68.
17. Boccardo, E., Noya, F., Broker, T.R., Chow, L.T., and Villa, L.L. (2004). HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes. Virology 328, 233-243.
18. Boehnke, K., Mirancea, N., Pavesio, A., Fusenig, N.E., Boukamp, P., and Stark, H.J. (2007). Effects of fibroblasts and microenvironment on epidermal regeneration and tissue function in long-term skin equivalents. Eur. J. Cell Biol. 86, 731-746.
19. Boelsma, E., Verhoeven, M.C., and Ponec, M. (1999). Reconstruction of a human skin equivalent using a spontaneously transformed keratinocyte cell line (HaCaT). J. Invest. Dermatol. 112, 489-498.
20. Boelsma, E., Gibbs, S., Faller, C., and Ponec, M. (2000). Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation. Acta Derm. Venereol. 80, 82-88.
21. Botham, P.A. (2004). The validation of in vitro methods for skin irritation. Toxicol. Lett. 149, 387-390.
22. Boyce, S.T., and Warden, G.D. (2002). Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am. J. Surg. 183, 445-456.
23. Butler, P.D., Ly, D.P., Longaker, M.T., and Yang, G.P. (2008). Use of organotypic coculture to study keloid biology. Am. J. Surg. 195, 144-148.
24. Cario-André, M., Pain, C., Gauthier, Y. et al. (2006). In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res. 19, 434-442.
25. Cario-André, M., Pain, C., Gauthier, Y., and Taïeb, A. (2007). The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res. 20, 385-393.
26. Chioni, A.M., and Grose, R. (2008). Organotypic modelling as a means of investigating epithelial-stromal interactions during tumourigenesis. Fibrogenesis Tissue Repair. 1, 8.
27. Chiu, L.L., Sun, C.H., Yeh, A.T., Torkian, B., Karamzadeh, A., Tromberg, B., and Wong, B.J. (2005). Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Lasers Surg. Med. 37, 231-244.
28. Cooper, M.L., Hansbrough, J.F., Spielvogel, R.L., Cohen, R., Bartel, R.L., and Naughton, G. (1991). In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 12, 243-248.
29. Costin, G.E., and Hearing, V.J. (2007). Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J. 21, 976-994.
30. Curren, R.D., Mun, G.C., Gibson, D.P., and Aardema, M.J. (2006). Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). Mutat. Res. 607, 192-204.
31. De Luca, M., Pellegrini, G., and Mavilio, F. (2009). Gene therapy of inherited skin adhesion disorders: a critical overview. Br. J. Dermatol. 161, 19-24.
32. Donahue, B.A., McArthur, J.G., Spratt, S.K. et al. (1999). Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med. 1, 31-42.
33. Dubé, J., Rochette-Drouin, O., Lévesque, P. et al. (2010). Restoration of the transepithelial potential within tissue-engineered human skin in vitro and during the wound healing process in vivo. Tissue Eng Part A 32, 238-243.
34. El Ghalbzouri, A., Gibbs, S., Lamme, E., Van Blitterswijk, C.A., and Ponec, M. (2002a). Effect of fibroblasts on epidermal regeneration. Br. J. Dermatol. 147, 230-243.
35. El Ghalbzouri, A., Lamme, E., and Ponec, M. (2002b). Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res. 310, 189-199.
36. El Ghalbzouri, A., Jonkman, M.F., Dijkman, R., and Ponec, M. (2005). Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/or exogenously activated keratinocytes. J. Invest. Dermatol. 124, 79-86.
37. El Ghalbzouri, A., Siamari, R., Willemze, R., and Ponec, M. (2008). Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines. Toxicol In Vitro. 22, 1311-1320.
38. Ergün, S.S., Cek, D.I., and Demirkesen, C. (2002). Is facial resurfacing with monobloc full-thickness skin graft a remedy in xeroderma pigmentosum? Plast. Reconstr. Surg. 110, 1290-1293.
39. Facy, V., Flouret, V., Régnier, M., and Schmidt, R. (2004). Langerhans cells integrated into human reconstructed epidermis respond to known sensitizers and ultraviolet exposure. J. Invest. Dermatol. 122, 552-553.
40. Feliciani, C., Gupta, A.K., and Sauder, D.N. (1996). Keratinocytes and cytokine/growth factors. Crit. Rev. Oral Biol. Med. 7, 300-318.
41. Fentem, J.H., and Botham, P.A. (2002). ECVAM's activities in validating alternative tests for skin corrosion and irritation. Altern Lab Anim. 2, 61-67.
42. Fentem, J.H., Briggs, D., Chesné, C., Elliott, G.R., Harbell, J.W., Heylings, J.R., Portes, P., Roguet, R., van de Sandt, J.J., and Botham, P.A. (2001). A prevalidation study on in vitro tests for acute skin irritation. Results and evaluation by the Management Team. Toxicol. In Vitro 15, 57-93.
43. Fernández, Y., Miller, T.P., Denoyelle, C., Esteban, J.A., Tang, W.H., Bengston, A.L., and Soengas, M.S. (2006). Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell death. J. Biol. Chem. 281, 1107-1118.
44. Ferrari, S., Pellegrini, G., Matsui, T., Mavilio, F., and De Luca, M. (2006). Gene therapy in combination with tissue engineering to treat epidermolysis bullosa. Expert Opin. Biol. Ther. 6, 367-378.
45. Fimiani, M., Pianigiani, E., Di Simplicio, F.C., Sbano, P., Cuccia, A., Pompella, G., De Aloe, G., and Petraglia, F. (2005). Other uses of homologous skin grafts and skin bank bioproducts. Clin. Dermatol. 23, 396-402.
46. Fitzpatrick, T.B., and Szabo, G. (1959). The melanocyte: cytology and cytochemistry. Invest. Dermatol. 32, 197-209.
47. Gazel, A., Rosdy, M., Bertino, B., Tornier, C., Sahuc, F., and Blumenberg, M. (2006). A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis. J. Invest. Dermatol. 126, 2647-2657.
48. Godin, B., and Touitou, E. (2007). Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv. Drug Deliv. Rev. 59, 1152-1161.
49. Gontier, E., Cario-André, M., Lepreux, S., Vergnes, P., Bizik, J., Surlève-Bazeille, J.E., and Taïeb, A. (2002). Dermal nevus cells from congenital nevi cannot penetrate the dermis in skin reconstructs. Pigment Cell Res. 15, 41-48.
50. Gontier, E., Cario-André, M., Vergnes, P., Lepreux, S., Surlève-Bazeille, J.E., and Taïeb, A. (2004). The role of E-cadherin in nevogenesis: an experimental study using epidermal reconstructs. Exp. Dermatol. 13, 326-331.
51. Grinnell, F. (1976). Biochemical analysis of cell adhesion to a substratum and its possible relevance to cell metastasis. Prog. Clin. Biol. Res. 9, 227-236.
52. Grinnell, F. (2008). Fibroblast mechanics in three-dimensional collagen matrices. J Bodywork Mov. Ther. 12, 191-193.
53. Haass, N.K., Smalley, K.S., Li, L., and Herlyn, M. (2005). Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 18, 150-159.
54. Hansen, S.L., Voigt, D.W., Wiebelhaus, P., and Paul, C.N. (2001). Using skin replacement products to treat burns and wounds. Adv. Skin Wound Care 14, 37-44.
55. Herlin, C., Saunière, D., and Huertas, D. (2009). Xeroderma pigmentosum: radical therapeutic procedure on the face using artificial skin [in French]. Ann. Chir. Plast. Esthet. 54, 594-599.
56. Hoffmann, S., Saliner, A.G., Patlewicz, G., Eskes, C., Zuang, V., and Worth, A.P. (2008). A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals. Toxicol. Lett. 180, 9-20.
57. Horch, R.E., Kopp, J., Kneser, U., Beier, J., and Bach, A.D. (2005). Tissue engineering of cultured skin substitutes. J. Cell Mol. Med. 9, 592-608.
58. Horning, J.L., Sahoo, S.K., Vijayaraghavalu, S., Dimitrijevic, S., Vasir, J.K., Jain, T.K., Panda, A.K., and Labhasetwar, V. (2008). 3-D tumor model for in vitro evaluation of anticancer drugs. Mol. Pharm. 5, 849-862.
59. Hoskins, E.E., Morris, T.A., Higginbotham, J.M., Spardy, N., Cha, E., Kelly, P., Williams, D.A., Wikenheiser-Brokamp, K.A., Duensing, S., and Wells, S.I. (2009). Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture. Oncogene 28, 674-685.
60. Hsu, M.Y., Meier, F.E., Nesbit, M., Hsu, J.Y., Van Belle, P., Elder, D.E., and Herlyn, M. (2000). E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156, 1515-1525.
61. Hu, T., Kaluzhny, Y., Mun, G.C., Barnett, B., Karetsky, V., Wilt, N., Klausner, M., Curren, R.D., and Aardema, M.J. (2009). Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. Mutat. Res. 673, 100-108.
62. Iozzo, R.V. (2005). Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell Biol. 6, 646-656.
63. Khorshid, F.A. (2005). Comparative study of keloid formation in humans and laboratory animals. Med. Sci. Monit. 11, BR212-BR219.
64. Konstantinova, N.V., Duong, D.M., Remenyik, E., Hazarika, P., Chuang, A., and Duvic, M. (1996). Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. J. Invest. Dermatol. 107, 615-621.
65. Levy, C., Khaled, M., and Fisher, D.E. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406-414.
66. Lin, C.Q., and Bissell, M.J. (1993). Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7, 737-743.
67. Liu, Y., Suwa, F., Wang, X., Takemura, A., Fang, Y.R., Li, Y., Zhao, Y., and Jin, Y. (2007). Reconstruction of a tissue-engineered skin containing melanocytes. Cell Biol. Int. 31, 985-990.
68. MacNeil, S. (2007). Progress and opportunities for tissue-engineered skin. Nature 44, 874-880.
69. Mancuso, M., Gallo, D., Leonardi, S. et al. (2009). Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer. Carcinogenesis. 30, 340-347.
70. Marinkovich, M.P., Lunstrum, G.P., Keene, D.R., and Burgeson, R.E. (1992). The dermal-epidermal junction of human skin contains a novel laminin variant. J. Cell Biol. 119, 695-703.
71. Mavilio, F., Pellegrini, G., Ferrari, S. et al. (2006). Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat. Med. 12, 1397-1402.
72. Mazzoleni, G., Di Lorenzo, D., and Steimberg, N. (2009). Modelling tissues in 3D: the next future of pharmaco-toxicology and food research? Genes Nutr. 4, 13-22.
73. Meier, F., Nesbit, M., Hsu, M.Y. et al. (2000). Human melanoma progression in skin reconstructs: biological significance of bFGF. Am. J. Pathol. 156, 193-200.
74. Menon, G.K. (2002). New insights into skin structure: scratching the surface. Adv. Drug Deliv Rev. 54(Suppl 1), S3-S17.
75. Moll, R., and Moll, I. (1998). Epidermal adhesion molecules and basement membrane components as target structures of autoimmunity. Virchows Arch. 432, 487-504.
76. Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., and Cone, R.D. (1992). The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
77. Nakazawa, K., Kalassy, M., Sahuc, F., Collombel, C., and Damour, O. (1998). Pigmented human skin equivalent - as a model of the mechanisms of control of cell-cell and cell-matrix interactions. Med. Biol. Eng. Comput. 36, 813-820.
78. Nemecek, G.M., and Dayan, A.D. (1999). Safety evaluation of human living skin equivalents. Toxicol. Pathol. 27, 101-103.
79. Nolte, S.V., Xu, W., Rennekampff, H.O., and Rodemann, H.P. (2008). Diversity of fibroblasts - a review on implications for skin tissue engineering. Cells Tissues Organs. 187, 165-176.
80. Okazaki, M., Suzuki, Y., Yoshimura, K., and Harii, K. (2005). Construction of pigmented skin equivalent and its application to the study of congenital disorders of pigmentation. Scand. J. Plast. Reconstr. Surg. Hand Surg. 39, 339-343.
81. Pageon, H., and Asselineau, D. (2005). An in vitro approach to the chronological aging of skin by glycation of the collagen: the biological effect of glycation on the reconstructed skin model. Ann. N Y Acad. Sci. 1043, 529-532.
82. Pasonen-Seppänen, S., Suhonen, T.M., Kirjavainen, M., Miettinen, M., Urtti, A., Tammi, M., and Tammi, R. (2001). Formation of permeability barrier in epidermal organotypic culture for studies on drug transport. J. Invest. Dermatol. 117, 1322-1324.
83. Paulitschke, V., Schicher, N., Szekeres, T. et al. (2010). 3, 3', 4, 4', 5, 5'-Hexahydroxystilbene impairs melanoma progression in a metastatic mouse model. J. Invest. Dermatol. 130, 1668-1679.
84. Phillips, T.J. (1998). New skin for old: developments in biological skin substitutes. Arch. Dermatol. 134, 344-349.
85. Ponec, M. (2002). Skin constructs for replacement of skin tissues for in vitro testing. Adv. Drug Deliv. Rev. 54(Suppl. 1), S19-S30.
86. Ponec, M., Gibbs, S., Weerheim, A., Kempenaar, J., Mulder, A., and Mommaas, A.M. (1997). Epidermal growth factor and temperature regulate keratinocyte differentiation. Arch. Dermatol. Res. 289, 317-326.
87. Portes, P., Grandidier, M.H., Cohen, C., and Roguet, R. (2002). Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study. Toxicol In Vitro 16, 765-770.
88. Pruniéras, M., Régnier, M., and Woodley, D. (1983). Methods for cultivation of keratinocytes with an air-liquid interface. J. Invest. Dermatol. 81, 28s-33s.
89. Rees, J.L. (2003). Genetics of hair and skin color. Annu. Rev. Genet. 37, 67-90.
90. Régnier, M., Caron, D., Reichert, U., and Schaefer, H. (1993). Barrier function of human skin and human reconstructed epidermis. J. Pharm. Sci. 82, 404-407.
91. Régnier, M., Staquet, M.J., Schmitt, D., and Schmidt, R. (1997). Integration of Langerhans cells into a pigmented reconstructed human epidermis. J. Invest. Dermatol. 109, 510-512.
92. Régnier, M., Patwardhan, A., Scheynius, A., and Schmidt, R. (1998). Reconstructed human epidermis composed of keratinocytes, melanocytes and Langerhans cells. Med. Biol. Eng. Comput. 36, 821-824.
93. Régnier, M., Duval, C., and Schmidt, R. (1999). Potential cosmetic applications of reconstructed epidermis. Int. J. Cosmet. Sci. 21, 51-58.
94. Rheinwald, J.G., and Green, H. (1975). Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6, 331-343.
95. Schoop, V.M., Mirancea, N., and Fusenig, N.E. (1999). Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J. Invest. Dermatol. 112, 343-353.
96. Schulz III, J.T., Tompkins, R.G., and Burke, J.F. (2000). Artificial skin. Annu. Rev. Med. 51, 231-244.
97. de Silva, O., and European Federation of the Cosmetics Industry, Steering Committee on Alternatives to Animal Testing (2002). The contributions of the European cosmetics industry to the development of alternatives to animal testing: dialogue with ECVAM and future challenges. Altern. Lab. Anim. 2, 189-193.
98. Smalley, K.S., Lioni, M., and Herlyn, M. (2006). Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell. Dev. Biol. Anim. 42, 242-247.
99. Sobral, C.S., Gragnani, A., Cao, X., Morgan, J.R., and Ferreira, L.M. (2007). Human keratinocytes cultured on collagen matrix used as an experimental burn model. J Burns Wounds 7, e6.
100. Sok, J., Pineau, N., Dalko-Csiba, M., Breton, L., and Bernerd, F. (2008). Improvement of the dermal epidermal junction in human reconstructed skin by a new c-xylopyranoside derivative. Eur. J. Dermatol. 18, 297-302.
101. Souto, L.R., Vassallo, J., Rehder, J., Pinto, G.A., and Puzzi, M.B. (2009). Immunoarchitectural characterization of a human skin model reconstructed in vitro. Sao Paulo Med. J. 127(1), 28-33.
102. Stark, H.J., Szabowski, A., Fusenig, N.E., and Maas-Szabowski, N. (2004a). Organotypic cocultures as skin equivalents: a complex and sophisticated in vitro system. Biol. Proc. Online 6, 55-60.
103. Stark, H.J., Willhauck, M.J., Mirancea, N., Boehnke, K., Nord, I., Breitkreutz, D., Pavesio, A., Boukamp, P., and Fusenig, N.E. (2004b). Authentic fibroblast matrix in dermal equivalents normalises epidermal histogenesis and dermoepidermal junction in organotypic co-culture. Eur. J. Cell Biol. 83, 631-645.
104. Stark, H.J., Boehnke, K., Mirancea, N., Willhauck, M.J., Pavesio, A., Fusenig, N.E., and Boukamp, P. (2006). Epidermal homeostasis in long-term scaffold-enforced skin equivalents. J. Invest. Dermatol. Symp. Proc. 11, 93-105.
105. Steingrímsson, E., Copeland, N.G., and Jenkins, N.A. (2004). Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet. 38, 365-411.
106. Tiznado-Orozco, T., and Orea-Solano, M. (2004). Dendritic cells and their role in atopic dermatitis. Rev. Alerg. Mex. 51, 119-123.
107. Tjabringa, G., Bergers, M., van Rens, D., de Boer, R., Lamme, E., and Schalkwijk, J. (2008). Development and validation of human psoriatic skin equivalents. Am. J. Pathol. 173, 815-823.
108. Welss, T., Basketter, D.A., and Schröder, K.R. (2004). In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol In Vitro 18, 231-243.
109. Wong, T., McGrath, J.A., and Navsaria, H. (2007). The role of fibroblasts in tissue engineering and regeneration. Br. J. Dermatol. 156, 1149-1155.
110. Yang, J., Balakrishnan, A., Hamamoto, S., Beattie, C.W., Das Gupta, T.K., Wellings, S.R., and Nandi, S. (1987). Different mitogenic and phenotypic responses of human breast epithelial cells grown in two versus three dimensions. Exp. Cell Res. 167, 563-569.
111. Youssef, K.K., Van Keymeulen, A., Lapouge, G., Beck, B., Michaux, C., Achouri, Y., Sotiropoulou, P.A., and Blanpain, C. (2010). Identification of the cell lineage at the origin of basal cell carcinoma. Nat. Cell Biol. 12, 299-305.
112. Yu, H., McDaid, R., Lee, J. et al. (2009). The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. Am. J. Pathol. 174, 2367-2377.